Moderna to build mRNA vaccine manufacturing facility in Quebec
Maddie Meyer/Getty Images News         

Moderna (NASDAQ:MRNA) will construct a manufacturing facility in the Canadian province of Quebec capable of producing up to 100M mRNA vaccine doses a year.
Construction will begin this year and the site is expected to be operational by the end of 2024.
Moderna signed a Memorandum of Understanding with the Government of Canada for the facility in August 2021.